Specific chromosomal aberrations as prognosticators in lymph-node negative breast cancer
- Prosjektnummer
- 911108
- Ansvarlig person
- Jan P. A. Baak
- Institusjon
- Helse Stavanger HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Lunge og bryst
- Forskningsaktivitet
Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.
J Clin Oncol 2005 Sep;23(25):5993-6001.
PMID: 16135467
Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.
Eur J Cancer 2005 Sep;41(14):2093-101.
PMID: 16153819
DNA ploidy analysis in histopathology. Morphometry and DNA cytometry reproducibility conditions and clinical applications.
Histopathology 2004 Jun;44(6):603-14.
PMID: 15186276
Prognostic value of proliferation in invasive breast cancer: a review.
J Clin Pathol 2004 Jul;57(7):675-81.
PMID: 15220356
PREDICTIVE VALUE OF AKT-PATHWAY CHARACTERISTICS, AND PROLIFERATION IN NODE-NEGATIVE INVASIVE BREAST CANCER PATIENTS UNDER 55 Y
poster PTEN pathways meeting CSHL, New York, USA
WHICH FACTORS DETERMINE THE SUCCESS OF ADJUVANT CHEMOTHERAPY IN NODE-NEGATIVE BREAST CANCER PATIENTS UNDER 55 YEARS?
In preparation
PREDICTIVE VALUE OF PROLIFERATION, PTEN AND AKT-PATHWAY CHARACTERISTICS IN NODE-NEGATIVE INVASIVE BREAST CANCER PATIENTS UNDER 5
In preparation
HIGH PROLIFERATION AND FIBROTIC FOCUS IN YOUNG NODE NEGATIVE BREAST CANCER PATIENTS INDICATE A VERY POOR SURVIVAL
In preparation
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest